alpha-conotoxin imi has been researched along with Leukemia in 1 studies
*Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hartmann, JX; Keating, P; Marí, F; Padilla, A | 1 |
1 other study(ies) available for alpha-conotoxin imi and Leukemia
| Article | Year |
|---|---|
Effects of α-conotoxin ImI on TNF-α, IL-8 and TGF-β expression by human macrophage-like cells derived from THP-1 pre-monocytic leukemic cells.
Topics: Animals; Anti-Inflammatory Agents; Cell Differentiation; Cell Proliferation; Cell Survival; Conotoxins; Humans; Interleukin-8; Leukemia; Lipopolysaccharides; Macrophages; Mice; Monocytes; Nicotine; RAW 264.7 Cells; Tetradecanoylphorbol Acetate; THP-1 Cells; Time Factors; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2017 |